Bioaffinity Technologies Inc.
13F holders, Q2 2026 (June 30)20holders +6
9new positions
4sold out
$0.97avg. 13F price*
At the end of Q2 2026, 20 institutions reported holding Bioaffinity Technologies Inc. in their 13F filings, up 6 from Q1 2026. 9 opened new positions and 4 sold out. The largest holders were Sabby Management, LLC ($297K), J. Safra Sarasin Holding AG ($164K) and BlackRock, Inc. ($80K).
- Company
- Bioaffinity Technologies Inc.
- CUSIP
- 09076W307
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2026 → Q2 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 9 | $463K |
| Exits | 4 | $98K |
All 13F filers, Q1 2026 → Q2 2026: 592,190 shares bought and 30,481 shares sold, net +561,709 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 20 holders
| Sabby Management, LLC | 2.51% | New | 365,647 | $297K |
| J. Safra Sarasin Holding AG | 0.00% | No change | 42,600 | $164K |
| BlackRock, Inc. | 0.00% | New | 98,777 | $80K |
| Vanguard Capital Management LLC | 0.00% | No change | 55,543 | $45K |
| Geode Capital Management, LLC | 0.00% | Add +5.5% | 50,967 | $41K |
| Vanguard Fiduciary Trust Co. | 0.00% | No change | 31,071 | $25K |
| Susquehanna International Group, LLP | 0.00% | New | 26,870 | $22K |
| Jane Street Group, LLC | 0.00% | New | 26,784 | $22K |
| State Street Corp. | 0.00% | Add +67.4% | 24,086 | $20K |
| HRT Financial LP | 0.00% | New | 20,834 | $16K |
| Northern Trust Corp. | 0.00% | Add +31.6% | 16,748 | $14K |
| Virtu Financial LLC | 0.00% | New | 11,113 | $9K |
| Parrish Capital LLC | 0.01% | New | 10,418 | $8K |
| Allworth Financial LP | 0.00% | New | 10,000 | $8K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +214.2% | 6,482 | $5K |
| UBS Group AG | 0.00% | Reduce -54.4% | 4,204 | $3K |
| EMC Capital Management | 0.00% | — | 2,001 | $1K |
| Royal Bank of Canada | 0.00% | New | 931 | $1K |
| IFP Advisors, Inc | 0.00% | No change | 833 | $676 |
| Morgan Stanley | 0.00% | No change | 3 | $2 |
"% of holder's portfolio" is BIOAFFINITY TECHNOLOGIES INC's weight in each manager's 13F, not the share of Bioaffinity Technologies Inc. the manager owns.